Dr. John Ervin began conducting clinical trials in 1986 simply to provide his rheumatology patients with new treatment options. What started as a doctor's dream to offer cutting-edge treatments to his patients has grown into a large, full-service clinical research site with specialists in nearly all Therapeutic Areas areas.
Over the past 24 years, The Center for Pharmaceutical Research has conducted over 475 studies in all areas of multispecialty research and employs nearly 50 healthcare professionals.
Dr. Ervin has earned a reputation for excellence in Kansas City and the national research community. The Center for Pharmaceutical Research's commitment to excellence is demonstrated not only by the compassionate treatment they provide, but also by their strict adherence to protocol and FDA guidelines.
Our study enrollment statistics speak for themselves, and the awards CPR has received demonstrate the respect the community has for Dr. Ervin and CPR. The Center for Pharmaceutical Research was recently recognized by The Kansas City Business Journal as one of the "Best Places to Work in Kansas City." In addition, Dr. Ervin has received numerous awards, including Kansas City's Rheumatology "Super Doctor" as chosen by peers in 2007 and 2008 and received the "Patient's Choice Award" in 2008.
Now, more than ever, Dr. Ervin and The Center for Pharmaceutical Research are dedicated to investigating new treatment and prevention options in all Therapeutic Areas areas. Through clinical trials, The Center for Pharmaceutical Research and our volunteers are truly advancing medicine and changing lives.